Madrigal Pharmaceuticals Company Description

Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.

It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania.

Madrigal Pharmaceuticals, Inc.

Country	United States
Industry	Pharmaceutical Preparations
Employees	528
CEO	William Sibold

Contact Details

Address: Four Tower Bridge West Conshohocken, Pennsylvania 19428 United States
Phone	267 824 2827
Website	madrigalpharma.com

Stock Details

Ticker Symbol	0JXI
Exchange	London Stock Exchange
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	US5588681057
SIC Code	2834

Key Executives

Name	Position
William J. Sibold	Chief Executive Officer, President and Director
Dr. Rebecca A. Taub M.D.	Founder, Senior Scientific and Medical Advisor and Director
Mardi C. Dier	Executive Vice President and Chief Financial Officer
Shannon Kelley	Executive Vice President, Chief Legal Officer and Corporate Secretary
Carole Huntsman	Executive Vice President and Chief Commercial Officer
Mark Underwood	Executive Vice President of Business Planning and Operations
Rita Thakkar	Senior Vice President and Chief Accounting Officer
Ronald Filippo	Executive Vice President and Chief Information Officer
Tina E. Ventura	Chief Investor Relations Officer
Clint Wallace	Executive Vice President and Chief Human Resources Officer